Shire Set To Recommend New AbbVie Offer After Latest Talks
This article was originally published in The Pink Sheet Daily
Executive Summary
Shire says it is willing to recommend to shareholders an AbbVie takeover for £31.4 billion ($53.8 billion) in cash and stock after the U.S. drugmaker proposed to increase its offer again.